Rayos Oral Tablet, Gastro-Resistant 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

RAYOS: Oral tablet, gastro-resistant (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_15925.JPG
RAYOS 1mg DR Tablet
Horizon Pharma, Inc
Pill Identification: NP 1 

What is this Medicine?

PREDNISONE (PRED ni sone) is a corticosteroid. It is commonly used to treat inflammation of the skin, joints, lungs, and other organs. Common conditions treated include asthma, allergies, and arthritis. It is also used for other conditions, such as blood disorders and diseases of the adrenal glands.

CVS Pharmacy Patient Statistics for RAYOS: Oral tablet, gastro-resistant(1mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

RAYOS 1mg Delayed-Release Tablet

NDC: 759870020
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Temporal Arteritis, Tenosynovitis, Tuberculosis Infection, Systemic Lupus Erythematosus (SLE), Pneumonitis, Adrenocortical Insufficiency, Crohn's Disease, Eczema, Congenital Adrenal Hyperplasia, Dermatitis, Dermatitis Herpetiformis, Rheumatoid Arthritis, Rheumatic Carditis, Nephrotic Syndrome, Idiopathic Thrombocytopenic Purpura (ITP), Allergic Conjunctivitis, Kidney Transplant Rejection Prophylaxis, Exfoliative Dermatitis, Polychondritis, Polyarteritis Nodosa, Angioedema, Urticaria, Uveitis, Polymyalgia Rheumatica, Acute Respiratory Distress Syndrome (ARDS), Addison's Disease, Iritis, Lupus Nephritis, Dermatomyositis, Chronic Lymphocytic Leukemia (CLL), Ankylosing Spondylitis, Anterior Segment Inflammation, Contact Dermatitis, Berylliosis, Mycosis Fungoides, Acute Lymphocytic Leukemia (ALL), Pemphigus, Seborrheic Dermatitis, Loeffler's Syndrome, Bursitis, Epicondylitis, Vasculitis, Stevens-Johnson Syndrome, Atopic Dermatitis, Corneal Ulcer, Asthma, Hypoplastic Anemia, Ulcerative Colitis, Keratitis, Chorioretinitis, Myasthenia Gravis, Pulmonary Fibrosis, Sarcoidosis, Osteoarthritis, Polymyositis, Graft-versus-host Disease (GVHD), Gouty Arthritis, Thyroiditis, Thrombocytopenia, ACE-inhibitor Induced Angioedema, Hodgkin's Disease, Erythema Multiforme, Juvenile Rheumatoid Arthritis (JRA)/juvenile Idiopathic Arthritis (JIA), Hemolytic Anemia, Erythroblastopenia, Optic Neuritis, Hypercalcemia

Sometimes used for but not FDA approved for the following conditions:
Myoclonic Seizures, Multiple Myeloma, Pneumonia, Behcet's Syndrome, Pericarditis, Autoimmune Hepatitis, Amyloidosis, Duchenne Muscular Dystrophy, Carpal Tunnel Syndrome, Acute Interstitial Nephritis (AIN), Spinal Cord Compression, Infantile Spasms, Bell's Palsy, Mycobacterium Avium Complex Infection, Mixed Connective Tissue Disease, Heart Transplant Rejection Prophylaxis, Absence Seizures, Heart Transplant Rejection, Lennox-Gastaut Syndrome, Endophthalmitis, Wegener's Granulomatosis, Churg-Strauss Syndrome

Storage Information
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
RAYOS 1mg Delayed-Release Tablet
Drug Image file DrugItem_15925.JPG
Horizon Pharma, Inc
Pill Identification: NP 1 
Shape: round
Color: white,yellow
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with RAYOS

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.